SARAH ALLEY: Open Payments
NPI 1144624404 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$314 in 12 payments from 7 companies in 2025. Trend: 2023 $191 · 2024 $208 · 2025 $314
Food & beverage: $229Education: $85
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 3 | $134 |
| ABBVIE INC. | 3 | $55 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| PUMA BIOTECHNOLOGY, INC. | 1 | $17 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $16 |
Products named: Veozah, Nubeqa, EPKINLY, REXULTI, MYFEMBREE, IMBRUVICA, NERLYNX.
Industry payments across AZ — which companies pay providers there.
